Pathogenic effects of inhibition of mTORC1/STAT3 axis facilitates Staphylococcus aureus-induced pyroptosis in human

Ruiyuan Yao1, Yuhao Chen1,2, Huifang Hao1

  • 1State Key Laboratory of Reproductive Regulation and Breeding of Grassland Livestock, School of Life Sciences, Inner Mongolia University, Hohhot, 010070, China.

Abstract

Insights

Staphylococcus aureus infection triggers pyroptosis in human macrophages. Inhibiting the mTORC1/STAT3 pathway enhances this cell death, revealing a novel regulatory mechanism for pyroptosis.

Area of Science:

  • Immunology
  • Cell Biology
  • Microbiology

Background:

  • Pyroptosis is a caspase-mediated cell death pathway activated by microbes or chemotherapy.
  • The precise regulatory mechanisms of pyroptosis remain incompletely understood.

Purpose of the Study:

  • To investigate the role of Staphylococcus aureus in inducing pyroptosis in human macrophages.
  • To elucidate the regulatory mechanism of the mTORC1/STAT3 axis in macrophage pyroptosis.

Main Methods:

  • Utilized laser confocal microscopy, TEM, live/dead cell assays, Western blot, immunohistochemistry, IFA, SEM, and ELISA.
  • Detected intracellular S. aureus, quantified macrophage death, and analyzed protein expression.
  • Observed pyroptotic morphology and cytokine release.

Main Results:

  • S. aureus infection induced pyroptosis in human macrophages, characterized by NLRP3 and Caspase-1 activation, GSDMD-NT pore formation, and IL-1β/IL-18 release.
  • Inhibition of mTORC1 or STAT3, or their combined axis, promoted S. aureus-induced pyroptosis.
  • mTORC1 regulated pyroptotic gene expression via STAT3 nuclear localization.

Conclusions:

  • S. aureus infection triggers pyroptosis in human macrophages.
  • The mTORC1/STAT3 axis plays a crucial regulatory role in macrophage pyroptosis.
  • Inhibiting the mTORC1/STAT3 axis facilitates S. aureus-induced pyroptosis, presenting a novel regulatory mechanism.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.6K